ALBANY MEDICAL COLLEGE
Role of tumor biomechanics on drug-receptor engagement
Role of tumor biomechanics on drug-receptor engagement is a funding opportunity from ALBANY MEDICAL COLLEGE, up to 648579, closing May 31, 2031.
May 31, 2031
(1765d left)Overview
Project Summary / Abstract Monoclonal antibody (mAb) therapies targeting the human epidermal growth factor receptor 2 (HER2) have transformed the treatment of HER2-positive breast cancer. However, many patients develop resistance or fail to achieve durable remission, underscoring the limitations of receptor abundance…